Thus, these results confirmed again that reactivation of STAT3 by colivelin enhances the biological behavior of PCCs upon fraxetin treatment, and the STAT3 is crucial for the inhibitory effect of fraxetin on PDA. Here, STAT3 is linked to Patent ductus arteriosus.